VIM and endometrial cancer: The use of various micro-RNAs (miRNAs) targeting the Notch pathway hindered the proliferation of the CD44/CD133-positive subpopulation in endometrial cancer (miRNA134), limited the expression of vimentin (VIM), reduced EMT, and decreased tumour formation and invasiveness (miRNA-34a) [108,109].